Pregnancy Registries Should Not Be Mandated In Drug Label, Amgen Tells FDA
Executive Summary
Industry is challenging one of the central components of FDA's proposed rule on pregnancy and lactation labeling - that any existing registries for patients should be included in labeling
You may also be interested in...
FDA To Evaluate Prescribing In Pregnancy With “Mental Modeling” Of Doctors
An FDA study to monitor prescribing decisions among care physicians who treat pregnant women could help pave the way for a better understanding of how to communicate drug risks in general
FDA To Evaluate Prescribing In Pregnancy With “Mental Modeling” Of Doctors
An FDA study to monitor prescribing decisions among care physicians who treat pregnant women could help pave the way for a better understanding of how to communicate drug risks in general
Pregnancy Labeling: FDA Should Follow EMEA’s Lead On Classification, Firms Say
FDA should adopt the European Medicines Agency's categorizations of pregnancy risk information in labeling, industry recommends in comments on the agency's proposed rule